TEST LIMITED TO BERNESE MOUNTAIN DOGS ONLY

Antagene Histiocytic Sarcoma Genetic Risk Test subsidized by the BMDCA

Wednesday, May 13th, 8:30am-1:00pm, Conference Center

Deadline to register: April 27, 2026

***New option available this year: A bundle price to include the histio risk test, plus both DM SOD1A and SOD1B tests, and Type 1 von Willebrands, for only $30 additional ($168 value!)

Bundle price $80 for BMDCA members/$90 for non-members.***

IMPORTANT: Participants MUST DOWNLOAD, COMPLETE & SIGN the following REQUIRED DOCUMENTS (links provided in Description below) and bring completed paperwork to the clinic:

AGREEMENT* (only one per person)

SAMPLING CERTIFICATE* (one per dog tested)

FOUR-GENERATION HORIZONTAL PEDIGREE**

*Available in the Description below, along with FAQ and Home Collection Instructions

**Download from the Berner-Garde database https://bernergarde.org/DB/Default

NOTE: Cancellations without notice (i.e. no shows) will not be refunded.

Puppies under 3 months of age? Contact Julie Jackson at [email protected] to request cheek swabs.

OPTIONAL HEALTH STUDY FOR DOGS AGE 6 & OLDER AT TIME OF TEST: Liquid Biopsy Study on early cancer screening for Histiocytic Sarcoma. This research is led by Dr. Benoit Hedan, Dog Genetics Team, IGDR, University of Rennes, France. Dogs 6 years or older, and cancer free are needed. Blood draw will occur in conjunction with the Histiocytic Sarcoma Risk Test Clinic. (Unfortunately, participation is limited to dogs in attendance.) This blood draw is supported by the BMDCA at no charge to participants. For more information, see Liquid Biopsy product.

Questions? Contact Julie Jackson at [email protected] or cell (206) 930-3290.

Histiocytic Sarcoma Risk Test

From $50

Part Number: BMDCA-HRT

Availability: In Stock

Options *

Participation *

In-Person (blood drawn at specialty clinic) Remote (blood drawn by own vet; hand-delivered on day of clinic)

Registered Name of Dog *

Required (no titles):

Call Name *

Required:

Date of Birth (MM/DD/YY) *

Required:

Sex (required) *

Male Female

Identification *

Required (Chip or Tattoo No.):

Berner-Garde ID# *

Insert:

Your Kennel Name

(Insert n/a if not applicable):

HSIMS Access (choose one) *

Self (authorized user on the HSIMS test mating website) Other (HSIMS user access granted to breeder/other)

Provide name & email in Comments.

I am interesting in participating in the optional health study for early cancer detection

For Dogs Aged Six & Older

The item you are trying to purchase is currently out of stock.
Please enter your name, email, and phone number below.
We will contact you as soon as this product is available.

Name: *

Email: *

Phone: *

Verification: *

Type the word above...

Quantity

Description

REQUIRED FORMS

Memorandum of Agreement/Terms & Conditions (Only one Agreement required per owner/breeder participating in clinic)

Sampling Certificate

4 Generation Pedigree (download from the Berner-Garde database for each dog being tested https://bernergarde.org/DB/Default)

CLINIC & RISK TEST INFORMATION

Frequently Asked Questions (FAQ )

Home Instructions (for samples hand-delivered to the in-person clinic)

Overview of Antagene's HSIMS Mate Selection Tool

Direct all questions not addressed in the Home Instructions or FAQ to Julie Jackson at [email protected]

IMPORTANT NOTE: The individual listed as "Owner" will receive results by email AND will be the only authorized user* for the tested dog on the HSIMS test mating website. If you prefer your Breeder/Co-Owner receive the results/breeder tool access, list that individual's name and email in the Comment section. *ONLY ONE USER PER DOG.

The ANTAGENE Laboratory, in collaboration with the CNRS Canine Genetics Team, has agreed to partner with the BMDCA to offer a clinic for the Histiocytic Sarcoma Risk Test at the BMDCA National Specialty. Normal price per dog is ~$120USD but BMDCA is pleased to announce special subsidized pricing for this clinic, with rates as low as $50! (See Options)

For over ten years, the Canine Genetics team of the CNRS in Rennes (France) and their international collaborators have been conducting genetic studies on Histiocytic Sarcoma in the Bernese Mountain Dog. These studies allowed them to locate regions of the genome implicated in this disease. The analysis of a large number of samples (more than 2000 Bernese Mountain Dogs) from affected dogs as well as old healthy dogs has enabled researchers to identify genetic markers associated with risk of developing and transmitting this cancer. Studies continue to investigate these genomic regions. Statistical analysis of these genetic markers has been used to produce a genetic index. This index can help breeders in the selection of breeding stock and matings. It is not, however, a prediction of the occurrence of the disease. This test is only a probability test, based on information from a population of 2,000 French Bernese Mountain Dogs; validated on European and American populations (over 900 Bernese Mountain Dogs in the U.S.)

The test for Histiocytic Sarcoma is not an endpoint but a continuation of the research on Histiocytic Sarcoma. The test will be optimized and refined with advanced research. For this your participation is essential.

NOTE: DNA extracted from your dog's sample may be used for research in canine genetics.

Histiocytic Sarcoma Risk Test

Choose Options

Recently Viewed Items